Clearance: basic concept (in vitro) Update OCT 2010.

Slides:



Advertisements
Similar presentations
Karunya Kandimalla, Ph.D
Advertisements

PHARMACOKINETIC MODELS
Clinical Pharmacokinetics
Assignment 6 Metabolism
The half-life OCT 2010.
Advanced Medicinal Chemistry
Non compartmental analysis
Mathematic descript. of A) Biolog. processes affecting drugs B) Biolog. processes affected by drugs drugs Pharmacokinetics Mathematical expressions to.
Pharmacokinetics as a Tool
Pharmacotherapy in the Elderly Paola S. Timiras May, 2007.
Pharmacotherapy in the Elderly Judy Wong
A General Overview The primary function of transporters is to transport endogenous substances, such as hormones, glucose, and amino acids; however, many.
Nonlinear pharmacokinetics
Computational Biology, Part 18 Compartmental Analysis Robert F. Murphy Copyright  1996, All rights reserved.
Asmah Nasser, M.D. Pharmacokinetics.
Blood Glucose Regulation BIOE Glucose Regulation Revisited input: desired blood glucose output: actual blood glucose error: desired minus measured.
Body clear- 1 Body clearance OCT 2010 PL Toutain.
Week 3 - Biopharmaceutics and Pharmacokinetics
Practical Pharmacokinetics
Dr. Michael Fill, Lecturer
Species extrapolation with PBPK models
PLASMA CLEARANCE AND RENAL BLOOD FLOW
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
Quantitative Pharmacokinetics
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
Nonlinear Pharmacokinetics
Pharmacokinetics Introduction
From A Physiologic Perspective Chemical Clearance from the Body
Animal Studies and Human Health Consequences Sorell L. Schwartz, Ph.D. Department of Pharmacology Georgetown University Medical Center.
Louisiana Tech University Ruston, LA Slide 1 Compartmental Models Juan M. Lopez BIEN 501 Friday, May 09, 2008.
EMEA London Pharmacokinetic- pharmacodynamic integration in veterinary drug development: an overview P.L. Toutain National Veterinary School ;Toulouse.
Atelier PK sur articles. 5 thèmes Absorption / biodisponibilité Métabolisme hépatique et effet de premier passage Les modèles in vitro d’étude de l’absorption.
PHARMACOKINETIC MODELS
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
The General Concepts of Pharmacokinetics and Pharmacodynamics
Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.
Clearance Determinations Arthur G. Roberts. Routes of Elimination.
Clinical Pharmacokinetics Fundamental hypothesis: a relationship exists between the pharmacological or toxic response to a drug and the accessible concentration.
PHARMACOKINETICS Definition: quantitative study of drug absorption, distribution, metabolism, and excretion (ADME), and their mathematical relationship.
INTRODUCTION CLINICAL PHARMACOKINETICS
Phoenix WinNonLin Assignment Due Today Access Phoenix remotely.
MS Phoenix WinNonLin Project
Pharmacokinetic Models
Drug Transfer into Milk: Clinical Methods & Issues Patrick J. McNamara University of Kentucky College of Pharmacy College of Pharmacy.
杨宇 Department of physiology Shenyang Medical College Section 6 Use of Clearance Methods to Quantify Kidney Function Definition of clearance: The volume.
Dr. Rida Shabbir DPT IPMR KMU 1. Objectives Describe the concept of renal plasma clearance Use the formula for measuring renal clearance Use clearance.
Lecture 2 Clearance, maintenance dose and AUC
The General Concepts of Pharmacokinetics and Pharmacodynamics
Clearance and Renal Excretion Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University Tobruk,
Time Plasma Conc (hr) (mg/L) Below limit of detection 1 Compartment IV Analysis & Renal Elimination 500 mg of tobramycin.
Intrinsic Clearance Arthur G. Roberts. Hydrophobic vs. Hydrophilic more bound to plasma proteins more distributed throughout body more metabolized.
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
Physiology for Engineers
Lecture-8 Biopharmaceutics
CONCEPT OF PHARMACOKINETICS- ONE COMPARTMENT MODEL
Lab-3 practical pharmacology
Quantitative Pharmacokinetics
Protein in Basolateral Fluid (BSA) Cell Thickness/Diameter
Kinetics, Modeling Oct 19, 2009 Casarett and Doull,
Dosimetry and Kinetics
Kinetics, Modeling Oct 15, 2006 Casarett and Doull,
Clinical Pharmacokinetics
Plasma Clearance.
Hawler Medical University
LIMITATIONS OF CYTOTOXICITY assays
Biopharmaceutics Chapter-6
Q1: Drug A is a small and hydrophilic compound that distributes to extracellular fluids only. It has a volume of distribution of 5.6 L in a healthy 70-kg.
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
Presentation transcript:

Clearance: basic concept (in vitro) Update OCT 2010

Clearance: definition What is a definition Formal: –rate of drug elimination scaled by plasma concentration Operational –Volume of the plasma totally cleared by time unit

Operational definition Is the one that expresses what is observed, without regarding how it may be interpreted

Rate of elimination driving concentration Clearance = = dx /dt driving concentration Amount/Time concentration mass x T -1 mass x V -1 = V x T -1 Clearance: definition

Clearance : from in vitro to in vivo

cell dx/dt Driving concentration = constant analyte Clearance = = Volume of the solution totally cleared by time unit dx/dt Cst intrinsic = operational definition In vitro clearance

Taking into account the analyte input analyte (C in ) (C out ) Limiting factors analyte supply = Q x (C in ) capacity of the system to clear: Clint ° Q ° Clearance: in vitro vs. in vitro

Clearance : in vitro vs in vivo In vitro In vivo Diffusion analyte Flow (Q) °

Q x C in Q x C out Q x (C in - C out ) Cl = dX /dt C in (Driving concentration) = Q x [C in - C out ] C in o o o o = Q x E o flow extraction coefficient (ratio) Clearance: general model

Cl organ = Q organ x E organ Flow Flow organ Cl is the blood (plasma) volume which is totally cleared of the drug for a time unit. Clearance is expressed in terms of flow which makes its interpretation difficult for a clinician organism Clearance: general model extration ratio (0 to 1) no unit

Cl organ = Q organ x E organ = Q x organism C in - C out C in Cl organ = = organis m Rate of elimination C in Rem.:C in for an organism is the aortic blood concentration C in for an organ is either the aortic blood (eg. kidney) or portal blood (e.g.. liver) concentration Mass per time Concentration o o Clearance: general model

Quantifies elimination Is usually constant ( a parameter) Parameter controlling exposure (AUC) Relevance of the clearance concept

For its usefulness –e.g.: dose computation For its mechanistic value –understanding of mechanism Relevance of the clearance concept

1. To the whole body –plasma clearance (body, blood) 2. To a specific organ –liver / kidney / others 3. in vitro systems –hepatocytes (extrapolation from in vitro to in vivo) Application of the clearance concept

Classification of clearances (Cl) By organ liver : Clh kidney : Clr By mechanism metabolic clearance (Clh) excretion clearance (Clr) With respect to the matrix fluid blood plasma Application of the clearance concept